Clinical Trial

Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia

Name: Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia — clinical trial record (NCT05316493)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

To investigate the efficacy of weight management plus levonorgestrel intrauterine system (LNG-IUS) or megestrol acetate (MA) in obese patients with endometrial atypical hyperplasia (EAH) asking for conservative therapy.

Trial Details

NCT Number	NCT05316493
Lead Sponsor	Xiaojun Chen
Conditions	Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity
Enrollment	172 participants
Start Date	2022-06-13
Primary Completion	2026-02-28 (estimated)
Study Completion	2027-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-06-04